2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

James Symanowski, PhD

Chair
Levine Cancer Institute
1100 S. Tryon Street
Suite 220
Charlotte, NC
USA 28203

Papers:
8 A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)